OpenLegislation

Paragraph 1

Original text. Later amendments are not shown.

The modifications of the 2013 Regulations referred to in regulation 16 are that those Regulations are to be read as if—

(a)

in regulation 2 (interpretation)—

(i)

in the definition of “resident patient”, for “the United Kingdom is” there were substituted “immediately before exit day the United Kingdom was”;

(ii)

in the definition of “visiting patient”, for “a member State other than the United Kingdom is” there were substituted “immediately before exit day a member State other than the United Kingdom was”;

(b)

in the heading to regulation 5 (national contact point: information about treatment in another member State), for “another member State” there were substituted “a member State”;

(c)

in regulation 5—

(i)

for references to “other member States” there were substituted “member States”;

(ii)

for the reference to “another member State” there were substituted “a member State”;

(d)

regulation 5A (National Contact Point: information about prescriptions intended to be used in another member State) were omitted;

(e)

for regulation 6(1) (National Contact Point: cross-border co-operation) there were substituted—

“(1)

In so far as it considers it appropriate for the purposes of giving effect to regulation 16 of the National Health Service (Cross-Border Healthcare and Miscellaneous Amendments etc) (EU Exit) Regulations 2019, the NCP must co-operate with the national contact points in member States and any other national contact points established in the United Kingdom.”;

(f)

regulation 7 (National Contact Point: duty to consult) were omitted;

(g)

in regulation 12—

(i)

in paragraph (2) for “P is” there were substituted “immediately before exit day P was”;

(ii)

in paragraph (2)(a), for “is resident” there were substituted “was resident”;

(iii)

in paragraph (2)(b), for “is the competent member State” there were substituted “was the competent member State”;

(iv)

in paragraph (4)(b) at the end there were inserted “as it had effect immediately before exit day”;

(h)

the schedule (elements that must be included in prescriptions intended to be used in another member State) were omitted.